Metastatic small cell carcinoma of the prostate in an octogenarian with significant response to first-line chemotherapy
dc.contributor.author | Wood, Anthony | |
dc.contributor.author | Adra, Nabil | |
dc.contributor.author | Cheng, Liang | |
dc.contributor.author | Pili, Roberto | |
dc.contributor.department | Department of Pathology and Laboratory Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2017-06-21T16:41:11Z | |
dc.date.available | 2017-06-21T16:41:11Z | |
dc.date.issued | 2017-03 | |
dc.description.abstract | Patients with small cell carcinoma of the prostate generally present with metastatic disease and have an estimated life expectancy measured in months. In this brief report, we present a case of rapidly progressive metastatic small cell carcinoma of the prostate in an octogenarian with significant response to split-dosed cisplatin and etoposide. This case report shows that cautious treatment with platinum-based regimens should still be considered in elderly patients given the potential for improvement in performance status and quality of life with chemotherapy. Additionally, this case highlights that platinum-based regimens are still considered the therapeutic backbone of prostate cancers with a mixed small cell carcinoma and adenocarcinoma phenotype. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Wood A., Adra N., Cheng L., Pili R. (2017). Metastatic small cell carcinoma of the prostate in an octogenarian with significant response to first-line chemotherapy. Hematol Med Oncol 2: DOI: 10.15761/HMO.1000120 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/13140 | |
dc.language.iso | en | en_US |
dc.publisher | OAT | en_US |
dc.relation.isversionof | 10.15761/HMO.1000120 | en_US |
dc.relation.journal | Hematology & Medical Oncology | en_US |
dc.source | Publisher | en_US |
dc.subject | small cell carcinoma | en_US |
dc.subject | prostate | en_US |
dc.subject | chemotherapy | en_US |
dc.title | Metastatic small cell carcinoma of the prostate in an octogenarian with significant response to first-line chemotherapy | en_US |
dc.type | Article | en_US |